A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Wugen, Inc.
Wugen, Inc.
Beijing Biotech
Gyala Therapeutics
OneChain Immunotherapeutics
Otsuka Medical Devices Co., Ltd. Japan
Tr1X, Inc.
Chongqing Precision Biotech Co., Ltd
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Senlang Biotechnology Inc., Ltd.